BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19798624)

  • 81. Retinopathy of prematurity: New developments bring concern and hope.
    Darlow BA
    J Paediatr Child Health; 2015 Aug; 51(8):765-70. PubMed ID: 25757043
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity.
    Zepeda-Romero LC; Liera-Garcia JA; Gutiérrez-Padilla JA; Valtierra-Santiago CI; Avila-Gómez CD
    Eye (Lond); 2010 May; 24(5):931-3. PubMed ID: 19557020
    [No Abstract]   [Full Text] [Related]  

  • 83. Laser Therapy Versus Anti-VEGF Agents for Treatment of Retinopathy of Prematurity.
    Leskov I; Mukai S
    Int Ophthalmol Clin; 2015; 55(4):81-90. PubMed ID: 26322428
    [No Abstract]   [Full Text] [Related]  

  • 84. Present-day conservative treatment retinopathy of prematurity.
    Monika M; Katarzyna KK; Leszek K
    Klin Oczna; 2013; 115(1):65-8. PubMed ID: 23882745
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Refractive outcomes following the treatment of retinopathy of prematurity in the anti-VEGF era: a literature review.
    Abri Aghdam K; Khadamy J; Falavarjani KG; Tsui I
    J AAPOS; 2016 Dec; 20(6):539-540.e3. PubMed ID: 27810419
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Temporal macular dimple in retinopathy of prematurity.
    Behera UC; Tripathy D; Singh J
    JAMA Ophthalmol; 2015 Apr; 133(4):e145348. PubMed ID: 25856652
    [No Abstract]   [Full Text] [Related]  

  • 87. [Long-term effects of anti-VEGF therapy for retinopathy of prematurity].
    Krohne TU; Müller A; Larsen PP; Holz FG
    Ophthalmologe; 2018 Jun; 115(6):464-468. PubMed ID: 29654389
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Will the BEAT-ROP study results really beat ROP?
    Raizada S; Kandari JA; Sabti KA
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9288-9. PubMed ID: 22127432
    [No Abstract]   [Full Text] [Related]  

  • 89. Comment on "Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity".
    Er H
    Retina; 2009 Oct; 29(9):1380; author reply 1379-80. PubMed ID: 19934833
    [No Abstract]   [Full Text] [Related]  

  • 90. Bevacizumab for retinopathy of prematurity.
    Gole GA; Camuglia JE; Ells AL
    N Engl J Med; 2011 Jun; 364(24):2360-1; author reply 2362. PubMed ID: 21675896
    [No Abstract]   [Full Text] [Related]  

  • 91. Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors.
    Mintz-Hittner HA
    Early Hum Dev; 2012 Dec; 88(12):937-41. PubMed ID: 23078830
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Current Practice Patterns for Treatment of Retinopathy of Prematurity.
    Tawse KL; Jeng-Miller KW; Baumal CR
    Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):491-5. PubMed ID: 27183557
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Retinopathy of prematurity.
    Dammann O; Hartnett ME; Stahl A
    Dev Med Child Neurol; 2023 May; 65(5):625-631. PubMed ID: 36408783
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Retinopathy of prematurity.
    Asano MK; Dray PB
    Dis Mon; 2014 Jun; 60(6):282-91. PubMed ID: 24906674
    [No Abstract]   [Full Text] [Related]  

  • 95. Screening and Treatment in Retinopathy of Prematurity.
    Stahl A; Göpel W
    Dtsch Arztebl Int; 2015 Oct; 112(43):730-5. PubMed ID: 26568177
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Review of clinical trials in retinopathy of prematurity : Current state and future perspectives].
    Stahl A
    Ophthalmologe; 2018 Jun; 115(6):456-463. PubMed ID: 29789899
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Retinopathy of the premature: Update in screening and treatment].
    Bancalari M A; Schade R
    Rev Chil Pediatr; 2020 Feb; 91(1):122-130. PubMed ID: 32730423
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9).
    Yetik H
    Ophthalmology; 2015 Aug; 122(8):e49. PubMed ID: 26210602
    [No Abstract]   [Full Text] [Related]  

  • 99. Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9).
    Padhi TR; Besirli CG
    Ophthalmology; 2015 Aug; 122(8):e47-8. PubMed ID: 26210600
    [No Abstract]   [Full Text] [Related]  

  • 100. Retinopathy of prematurity: an eye toward better outcomes.
    Pollan C
    Neonatal Netw; 2009; 28(2):93-101. PubMed ID: 19332407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.